Masimo reports preliminary Q4 2023 rev $541-551M; FY2024 rev guidance $2.045-2.165B

MASIMO CORP

2023-FY EPS reported $1.51 revenue$2,048,100,000

Preliminary Q4 2023 consolidated revenue $541M-$551M; healthcare segment $336M-$341M.
Full-year 2023 consolidated revenue $2.041B-$2.051B; healthcare $1.272B-$1.277B.
FY2024 guidance: consolidated revenue $2.045B-$2.165B; healthcare $1.345B-$1.385B.
FY2024 GAAP EPS $1.91-$2.08; non-GAAP EPS (updated) $3.44-$3.60 (prior $3.00-$3.15).
Non-healthcare revenue expected to decline in FY2024 ($700M-$780M vs ~$771M in 2023).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MASIMO CORP reported the fourth quarter and full-year ended December 30, 2023 results: revenue Consolidated revenue of $541 million to $551 million. Guidance initiated.

Period: the fourth quarter and full-year ended December 30, 2023
Revenue: Consolidated revenue of $541 million to $551 million
Guidance: initiated
Result: preliminary results

Exact text from the filing

and full-year ended December 30, 2023 and provided estimates for its full-year 2024 guidance. Preliminary Fourth Quarter 2023 Financial Results: • Consolidated revenue of $541 million to $551 million; • Healthcare revenue of $336 million to $341 million; and • Non-healthcare revenue of $205 million to $210 million. Preliminary Full-Year 2023 Financial Results:

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

MASIMO CORP filing history →

Source: SEC EDGAR

accession 0000937556-24-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.